Latest News

FDA OKs Enzalutamide for Non-Metastatic Castration-Resistant Prostate Cancer
Enzalutamide (Xtandi) is the first and only FDA-approved oral medication for both non-metastatic and metastatic castration-resistant prostate cancer.
Study suggests that covering high-value medications benefits patients at no extra cost to insurers.
Tecovirimat (TPOXX, SIGA) is the first drug with an indication for the treatment of smallpox.
Researchers aim to determine whether an annual brain volume loss rate of less than 0.4% is a valid marker to assess treatment response.
Top news of the day from across the health care landscape.
The discontinuation of opioid therapy may address the rising death toll caused by drug overdoses while maintaining or potentially improving chronic, non-cancer pain in patients, according to a recent study.
Ron Lanton III, Esq., executive director and senior counsel for Frier Levitt Government Affairs, discusses how to boost prescriber uptake of biosimilars.
Cognitive impairment is present in up to 70% of patients with multiple sclerosis, but can be difficult to completely evaluate in routine clinical practice.


Specialty Pharmacies Honored for Exemplary Patient Support
The Specialty Pharmacy Patient Choice Award was created by Zitter Health Insights and Specialty Pharmacy Times in 2017 to honor specialty pharmacies and their commitment to patients.
While navigating the expanding marketplace, health care innovators must continue to cope with rising costs, barriers to access, and a complicated reimbursement environment.
Caught in the middle of a maelstrom of change currently engulfing the health care industry, specialty pharmacy is emerging as a powerful force that will play a key role in the growing conversations regarding value in health care.
As it is every year, the Asembia Summit was filled with a plethora of information that allowed for networking, business development, and personal development.

Featured Company Profile

MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy


Ron Lanton III, Esq., executive director and senior counsel for Frier Levitt Government Affairs, discusses how to boost prescriber uptake of biosimilars.

Luis Torres, MBA, Vice President, Managed Care, BioPlus Specialty Pharmacy, speaks about why data is a crucial component of choosing a specialty pharmacy.

A look at last week's top stories in the world of pharmacy.

Current Issue

2018 Asembia Recap
Volume: 9
Number: 4

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.